FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...